p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia - PubMed (original) (raw)
p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia
Rüdiger Klaes et al. Am J Surg Pathol. 2002 Nov.
Abstract
It has been repeatedly shown that there is a substantial lack of interobserver reproducibility in the histologic diagnosis of cervical intraepithelial neoplasia (CIN), which might be improved by a more specific diagnostic biomarker. Cervical cancer and CIN, but not other cervical epithelia, express high levels of the cyclin-dependent kinase inhibitor p16, suggesting that staining for this marker could help to more precisely identify CIN in tissue sections and therefore reduce variation in interpretation of cervical lesions. To test this hypothesis, 194 cervical cone biopsy samples were selected from a routine histopathology laboratory. Two consecutive sections from each biopsy were stained with hematoxylin and eosin and with a p16 -specific monoclonal antibody, respectively. Five experienced cervical pathologists examined the slides. The agreement in the diagnosis between pairs or groups of observers was calculated by kappa statistics. Significant discrepancies were observed in the diagnostic interpretation of hematoxylin and eosin-stained slides, particularly for low-grade lesions (kappa value 0.60 [95% confidence interval 0.58-0.63]). There was significantly better agreement in the interpretation of p16 expression (kappa value 0.91 [95% confidence interval 0.84-0.99]). Expression of p16 was restricted to CIN 2/CIN 3, CIN 1 associated with high-risk human papillomavirus, or cervical cancer. p16 immunostaining allowed precise identification of even small CIN or cervical cancer lesions in biopsy sections and helped to reduce interobserver variation in the histopathologic interpretation of cervical biopsy specimens. Thus, p16 immunohistochemistry can reduce false-negative and false-positive biopsy interpretation and thereby significantly improve cervical (pre)-cancer diagnosis.
Comment in
- p16INK4a IHC in the diagnosis of cervical CIN.
Ichinose H. Ichinose H. Am J Surg Pathol. 2003 Sep;27(9):1284; author reply 1284. doi: 10.1097/00000478-200309000-00013. Am J Surg Pathol. 2003. PMID: 12960814 No abstract available.
Similar articles
- Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia.
Horn LC, Reichert A, Oster A, Arndal SF, Trunk MJ, Ridder R, Rassmussen OF, Bjelkenkrantz K, Christiansen P, Eck M, Lorey T, Skovlund VR, Ruediger T, Schneider V, Schmidt D. Horn LC, et al. Am J Surg Pathol. 2008 Apr;32(4):502-12. doi: 10.1097/PAS.0b013e31815ac420. Am J Surg Pathol. 2008. PMID: 18223479 - Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry.
Tao AS, Zuna R, Darragh TM, Grabe N, Lahrmann B, Clarke MA, Wentzensen N. Tao AS, et al. Am J Clin Pathol. 2024 Aug 1;162(2):202-209. doi: 10.1093/ajcp/aqae029. Am J Clin Pathol. 2024. PMID: 38527169 - p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement.
Reuschenbach M, Wentzensen N, Dijkstra MG, von Knebel Doeberitz M, Arbyn M. Reuschenbach M, et al. Am J Clin Pathol. 2014 Dec;142(6):767-72. doi: 10.1309/AJCP3TPHV4TRIZEK. Am J Clin Pathol. 2014. PMID: 25389329 Review. - p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions.
Dijkstra MG, Heideman DA, de Roy SC, Rozendaal L, Berkhof J, van Krimpen K, van Groningen K, Snijders PJ, Meijer CJ, van Kemenade FJ. Dijkstra MG, et al. J Clin Pathol. 2010 Nov;63(11):972-7. doi: 10.1136/jcp.2010.078634. Epub 2010 Oct 5. J Clin Pathol. 2010. PMID: 20924035 - p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia.
Kalof AN, Cooper K. Kalof AN, et al. Adv Anat Pathol. 2006 Jul;13(4):190-4. doi: 10.1097/00125480-200607000-00006. Adv Anat Pathol. 2006. PMID: 16858153 Review.
Cited by
- Biomarkers of cervical dysplasia and carcinoma.
Hwang SJ, Shroyer KR. Hwang SJ, et al. J Oncol. 2012;2012:507286. doi: 10.1155/2012/507286. Epub 2011 Oct 29. J Oncol. 2012. PMID: 22131995 Free PMC article. - P16INK4a expression in patients with penile cancer.
Martins VA, Pinho JD, Teixeira Júnior AAL, Nogueira LR, Silva FF, Maulen VE, Khayat AS, Calixto JRR, Costa HA, Ramalho LNZ, Silva GEB. Martins VA, et al. PLoS One. 2018 Oct 12;13(10):e0205350. doi: 10.1371/journal.pone.0205350. eCollection 2018. PLoS One. 2018. PMID: 30312320 Free PMC article. - Early detection of cervical carcinomas: finding an overall approach.
Wentzensen N, Klug SJ. Wentzensen N, et al. Dtsch Arztebl Int. 2008 Sep;105(37):617-22. doi: 10.3238/arztebl.2008.0617. Epub 2008 Sep 12. Dtsch Arztebl Int. 2008. PMID: 19471627 Free PMC article. - The expression patterns of p53 and p16 and an analysis of a possible role of HPV in primary adenocarcinoma of the urinary bladder.
Alexander RE, Williamson SR, Richey J, Lopez-Beltran A, Montironi R, Davidson DD, Idrees MT, Jones CL, Zhang S, Wang L, Rao Q, Pedrosa JA, Kaimakliotis HZ, Monn MF, Koch MO, Cheng L. Alexander RE, et al. PLoS One. 2014 Apr 21;9(4):e95724. doi: 10.1371/journal.pone.0095724. eCollection 2014. PLoS One. 2014. PMID: 24752337 Free PMC article. - [Diagnosis and grading of cervical intraepithelial neoplasias].
Rosamilia C, Feichter G, Tzankov A, Obermann EC. Rosamilia C, et al. Pathologe. 2012 Mar;33(2):118-23. doi: 10.1007/s00292-011-1549-5. Pathologe. 2012. PMID: 22350168 German.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical